MiNK Therapeutics, Inc. (NASDAQ:INKT) Short Interest Down 76.4% in February

MiNK Therapeutics, Inc. (NASDAQ:INKT – Get Free Report) was the recipient of a significant decline in short interest during the month of February. As of February 29th, there was short interest totalling 41,300 shares, a decline of 76.4% from the February 14th total of 175,100 shares. Approximately 0.4% of the shares of the stock are […]

Related Keywords

,Mink Therapeutics Company Profile ,Nasdaq ,Wells Fargo Company ,Goldman Sachs Group Inc ,Millennium Management ,Mink Therapeutics Inc ,Get Free Report ,Sachs Group ,Street Corp ,Captrust Financial Advisors ,Mink Therapeutics ,Nasdaq Inkt ,Stinkt ,Medical ,Stocks ,Options ,Put ,Call ,